Cancer: Combating resistance to EGFR inhibitors

被引：5
|
作者：
Crunkhorn S.
机构：
来源：
Nature Reviews Drug Discovery | 2019年 / 18卷 / 1期
关键词：
D O I：
10.1038/nrd.2018.232
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：18 / 18
相关论文
共 50 条
  • [1] Natural products combating EGFR-TKIs resistance in cancer
    Xia, Li
    Zhu, Gaohui
    Peng, Qiyao
    Li, Xiuyang
    Zou, Xinrong
    Zhang, Wanping
    Zhao, Lulu
    Li, Xiong
    Wu, Ping
    Luo, Aimin
    Yang, Teng
    Chen, Meizi
    Liu, Teng
    Peng, Yongbo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2025, 13
  • [2] Mechanisms of resistance to EGFR inhibitors in lung cancer
    Kobayashi, Yoshihisa
    CANCER SCIENCE, 2025, 116 : 136 - 136
  • [3] Mechanisms of resistance to EGFR inhibitors in lung cancer
    Janne, Pasi
    CANCER RESEARCH, 2016, 76
  • [4] Drug Resistance to EGFR Inhibitors in Lung Cancer
    Tetsu, Osamu
    Hangauer, Matthew J.
    Phuchareon, Janyaporn
    Eisele, David W.
    McCormick, Frank
    CHEMOTHERAPY, 2015, 61 (05) : 223 - 235
  • [5] MECHANISMS OF RESISTANCE TO EGFR INHIBITORS IN HEAD AND NECK CANCER
    Cooper, Jonathan B.
    Cohen, Ezra Eddy Wyssam
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (08): : 1086 - 1094
  • [6] Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
    Leanne G. Ahronian
    Ryan B. Corcoran
    Genome Medicine, 9
  • [7] Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
    Ahronian, Leanne G.
    Corcoran, Ryan B.
    GENOME MEDICINE, 2017, 9
  • [8] Combating acquired resistance to KRAS inhibitors in NSCLC by targeting PTPRR-mediated activation of EGFR signaling
    Kanemura, Hiroaki
    Takehara, Toshiyuki
    Onodera, Yuta
    Teramura, Takeshi
    Suzuki, Shinichiro
    Sakai, Kazuko
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    Hayashi, Hidetoshi
    Yonesaka, Kimio
    CANCER SCIENCE, 2024, 115 : 422 - 422
  • [9] Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
    Bianco, R
    Troiani, T
    Tortora, G
    Ciardiello, F
    ENDOCRINE-RELATED CANCER, 2005, 12 : S159 - S171
  • [10] Depleting EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
    Yang, Lu
    Bhattacharya, Arup
    Li, Yun
    Sexton, Sandra
    Ling, Xiang
    Li, Fengzhi
    Zhang, Yuesheng
    CANCER RESEARCH, 2022, 82 (12)
12345